Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evotec SE (EVO) EBT (2020 - 2025)

Evotec SE's EBT history spans 6 years, with the latest figure at -$100.9 million for Q4 2025.

  • On a quarterly basis, EBT rose 51.3% to -$100.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$308.1 million, a 4.87% decrease, with the full-year FY2025 number at -$101.0 million, up 51.27% from a year prior.
  • EBT hit -$100.9 million in Q4 2025 for Evotec SE, down from -$50222.6 in the prior quarter.
  • Over the last five years, EBT for EVO hit a ceiling of $270.8 million in Q4 2021 and a floor of -$207.1 million in Q4 2024.
  • Historically, EBT has averaged -$18.7 million across 5 years, with a median of -$25967.9 in 2022.
  • Biggest five-year swings in EBT: skyrocketed 1784.32% in 2021 and later tumbled 258.07% in 2024.
  • Tracing EVO's EBT over 5 years: stood at $270.8 million in 2021, then plummeted by 158.05% to -$157.2 million in 2022, then skyrocketed by 44.88% to -$86.7 million in 2023, then crashed by 138.99% to -$207.1 million in 2024, then soared by 51.3% to -$100.9 million in 2025.
  • Business Quant data shows EBT for EVO at -$100.9 million in Q4 2025, -$50222.6 in Q3 2025, and -$207.1 million in Q4 2024.